Brief: Liminal Biosciences Reports Second Quarter 2022 Financial Results
09/08/2022 23:16
Aug 9 (Reuters) - Liminal BioSciences Inc LMNL.O :
* LIMINAL BIOSCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* LIMINAL BIOSCIENCES - NET LOSS FROM CONTINUING OPERATIONS
OF
$6.5 MILLION DURING QUARTER ENDED JUNE 30, 2022 VERSUS $12.6
MILLION
Source text for Eikon: ID:nCNW75q9ha
Further company coverage: LMNL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liminal BioSciences
See all newsBrief: Liminal Biosciences Announces Completion Of The Plan Of Arrangement With Structured Alpha Lp
Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular
Brief: Liminal Biosciences Obtains Interim Order For Proposed Arrangement With Structured Alpha Lp
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy